Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Vaximm
221
Vaximm
Technology
Biotechnology
Vaximm, a vaccine company based in Switzerland developing immunotherapies for cancer patients, offers VXM01 targeting tumor vasculature.
Suggest edits
Raised
$8M
Follow us
Companies in the same industry
Monte Rosa Therapeutics
NFlection Therapeutics
CARLSMED, Inc.
Arctic Vision
Sema4
GEN inCode
Korro Bio
Galecto, Inc.
Sensei Biotherapeutics
Enveda Biosciences
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$8,000,000
Venture capital - 2011
Team Size
1–10
Employees
I work here
Location
Switzerland
Headquarters
Explore Switzerland
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Vaximm makes some noise.
